Autologous Fat Grafting is Emerging as a Safer Substitute to Breast Enlargement Procedures – Fact.MR Detailed Study

According to Fact MR’s recent market research, sales of Autologous Fat Grafting to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Autologous Fat Grafting market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=2701

The global autologous fat grafting market is projected to expand at a healthy CAGR of close to 10% from 2021 to 2031. By application, breast augmentation holds the highest market share of over 45%.

Autologous fat grafting systems are used for precise and faster fat processing, which eliminates the use of laborious manual procedures. This makes the overall fat grafting process effective and more affordable. Autologous fat transfer systems and accessories find major application in minimal and non-invasive cosmetic procedures.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Autologous Fat Grafting market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Autologous Fat Grafting

The report offers actionable and valuable market insights of Autologous Fat Grafting. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Autologous Fat Grafting Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Autologous Fat Grafting, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Autologous Fat Grafting Market.

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=2701

Key Segments of Market

Product

• Integrated Fat Transfer Systems
• Aspiration and Harvesting Systems
• Liposuction Systems
• Fat Processing Systems
• De-epithelialization Devices
• Accessories
  • Fat Injection Cannulas
  • Fat Harvesting Cannulas
  • LuerLok Infiltrator Cannulas
  • Cannula Connectors & Single Use Fat Transfer
  • Tubing Sets

Application

• Autologous Fat Grafting for Breast Augmentation
• Autologous Fat Grafting for Buttock Augmentation
• Autologous Fat Grafting
• Autologous Fat Grafting for Hand Rejuvenation
• Others

End User

• Autologous Fat Grafting at Hospitals
• Autologous Fat Grafting at On-site Clinics
• Autologous Fat Grafting at Plastic Surgery Centers

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• The Middle East and Africa

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/2701

Competition Analysis

Fact.MR has profiled the following prominent autologous fat grafting stakeholders in its report:Acquisitions and new product launches among global and regional market players is a characteristic phenomenon of the overall competition in the market.

• For instance, in May 2020, AbbVie acquired Allergan plc to include several new products in the aesthetics and women’s health portfolio.
• In 2017, Allergan plc acquired Lifecell Corp. This acquisition was expected to help expand Allergan’s autologous fat grafting solutions and dermal matrix products, along with creating opportunities for the sales of new products.
• In 2018, Allergan acquired Elastagen, an exciting clinical-stage company with an advanced tissue repair platform based on tropoelastin.
• In 2019, Innova Medical collaborated with Medical Device Resource Corporation (MD Resource), a manufacturer and distributor of liposuction and fat transfer systems.
• Tulip has made its mark with the invention of the patented Syringe System, the patented SuperLuerLok hub, and the proprietary Cell Friendly technology.

Key Takeaways from Market Study

• Integrated fat transfer systems accounted for over 50% of market share in 2020.
• Breast augmentation is the most lucrative segment and holds a little less than half of the market share.
• North America accounts for over half of the global autologous fat grafting market share, owing to technological advancements and increasing research & development activities in this region.
• Hospitals account for over 48% value share, among end users.
• The COVID19 pandemic has resulted in a temporary pause of all non-essential and elective procedures. Pharmaceutical manufacturers have been severely impacted, with companies reporting a significant drop in revenue due to supply chain issues.
• The market in the U.S., U.K. and Germany to accelerate at around 10% CAGR each through 2031.
• The market in China to surge ahead at a CAGR of around 12% over the next ten years.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

The post Autologous Fat Grafting is Emerging as a Safer Substitute to Breast Enlargement Procedures – Fact.MR Detailed Study appeared first on Latest Market Reports.